Lysine

Lysine

SCHEMBL1281704

NCCCCC(N)C(=O)[O-].[Na+]

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ GSR P00390 1/20 0.61
▸ RNPEP Q9H4A4 1/20 0.43
▸ GNAI3 P08754 1/20 0.43
▸ GNAO1 P09471 1/20 0.43
▸ GNAI1 P63096 1/20 0.43
▸ DPP7 Q9UHL4 9/20 0.42
▸ DPP8 Q6V1X1 5/20 0.42
▸ DPP9 Q86TI2 5/20 0.42
▸ DPP4 P27487 3/20 0.42
▸ CPB2 Q96IY4 2/20 0.39
▸ FAP Q12884 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ MMP2 P08253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lysine SCHEMBL1281705 1.00 GSR (0.61) GSRRNPEPGNAI3GNAO1GNAI1
Lysine SCHEMBL6444907 0.96 GSR (0.63) GSRRNPEPGNAI3GNAO1GNAI1
Lysine SCHEMBL5062296 0.95 GSR (0.61) GSRRNPEPGNAI3GNAO1GNAI1
Lysine SCHEMBL6037599 0.95 GSR (0.61) GSRRNPEPGNAI3GNAO1GNAI1
Lysine SCHEMBL16194536 0.95 GSR (0.61) GSRRNPEPGNAI3GNAO1GNAI1
Lysine SCHEMBL25283016 0.95 GSR (0.61) GSRRNPEPGNAI3GNAO1GNAI1
Lysine SCHEMBL3517540 0.95 GSR (0.61) GSRRNPEPGNAI3GNAO1GNAI1
Lysine SCHEMBL121844 0.95 GSR (0.61) GSRRNPEPGNAI3GNAO1GNAI1
Lysine SCHEMBL3749535 0.95 GSR (0.61) GSRRNPEPGNAI3GNAO1GNAI1
Lysine SCHEMBL3739868 0.95 GSR (0.61) GSRRNPEPGNAI3GNAO1GNAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260042080-A1 SOLID SORBENT FOR REMOVAL OF CARBON DIOXIDE FROM A CO2-CONTAINING GAS SUSTAERA INC (US) 2026-02-12 — — US claimed
EP-4651974-A2 SOLID SORBENT FOR REMOVAL OF CARBON DIOXIDE FROM A CO2-CONTAINING GAS Sustaera Inc. (US) 2025-11-26 — — EP claimed
CN-119491025-A Preparation method of environment-friendly fatty acyl amino acid salt 广东植采生物科技有限公司 2025-02-21 — — CN claimed
US-20240359162-A9 METHOD OF FORMING INTEGRATED COMPOSITE COMPRISING CONDUCTIVE CARBON NETWORK SUSTAERA INC (US) 2024-10-31 — — US claimed
CN-116585519-B Peach leaf plant extract relieving and repairing essence disposable hygienic product nursing base material, preparation method and application 广东景兴健康护理实业股份有限公司 2024-09-24 — — CN claimed
WO-2024155658-A2 SOLID SORBENT FOR REMOVAL OF CARBON DIOXIDE FROM A CO2-CONTAINING GAS SUSTAERA INC. (US) 2024-07-25 — — WO claimed
CN-116531547-B Cedar plant extract anti-allergy repair essence disposable sanitary product nursing base material, preparation method and application 广东景兴健康护理实业股份有限公司 2024-07-12 — — CN claimed
US-20240075457-A1 METHOD OF FORMING INTEGRATED COMPOSITE COMPRISING CONDUCTIVE CARBON NETWORK SUSTAERA INC (US) 2024-03-07 — — US claimed
CN-116585519-A Peach leaf plant extract relieving and repairing essence disposable hygienic product nursing base material, preparation method and application 广东景兴健康护理实业股份有限公司 2023-08-15 — — CN claimed
CN-116531547-A Cedar plant extract anti-allergy repair essence disposable sanitary product nursing base material, preparation method and application 广东景兴健康护理实业股份有限公司 2023-08-04 — — CN claimed
CN-1839689-A Aartificial breedubg method for P.manil-lensis ZHOU WEIHAI (CN) 2006-10-04 — — CN claimed
EP-1515691-A1 STABILIZED ANTIPERSPIRANT COMPOSITIONS CONTAINING ALUMINUM-ZIRCONIUM SALTS WITH LOW M:CL RATIO THE GILLETTE COMPANY (US) 2005-03-23 — — EP claimed
US-6726901-B2 ALUMINUM ZIRCONIUM CHLOROHYDRATES; BASE SUSPENDED IN CARRIER; DEODORIZING THE GILLETTE COMPANY 2004-04-27 — — US claimed
WO-2003094880-A1 STABILIZED ANTIPERSPIRANT COMPOSITIONS CONTAINING ALUMINUM-ZIRCONIUM SALTS WITH LOW M:CL RATIO ­ THE GILLETTE COMPANY (US) 2003-11-20 — — WO claimed
US-20030211060-A1 Stabilized antiperspirant compositions containing aluminum-zirconium salts with low M:C1 ratio THE GILLETTE COMPANY 2003-11-13 — — US claimed
CN-1423929-A Cultivation method of Poecilobdella manillensis and extraction technology of hirudin ZHOU WEIHAI (CN) 2003-06-18 — — CN claimed
US-20030097149-A1 Pretreatment method for enhancing tissue adhesion ADVANCED CLOSURE SYSTEMS, INC. 2003-05-22 — — US claimed
EP-0969769-A2 VASCULAR SEALING DEVICE Advanced Closure Systems, Inc. (US) 2000-01-12 — — EP claimed
WO-1998040017-A2 VASCULAR SEALING DEVICE ADVANCED CLOSURE SYSTEMS, INC. (US) 1998-09-17 — — WO claimed
US-3941776-A RACEMIZATION OF AMINOLACTAM COMPOUNDS ALLIED CHEMICAL CORPORATION (US) 1976-03-02 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260042080-A1 SOLID SORBENT FOR REMOVAL OF CARBON DIOXIDE FROM A CO2-CONTAINING GAS SLC6A6, SLC6A19, SLC6A9 GSR 1440/4885RNPEP 1842/4885GNAI3 1836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback